Β 受体阻断药的临床试验
总计1545个结果
-
Regeneron Pharmaceuticals招聘中继发于 Otoferlin 基因双等位基因突变 (OTOF) 的先天性听力损失 | 间隙连接 Beta 2 (GJB2) 基因的双等位基因突变 | GJB2/间隙连接 Beta 6 (GJB6) 基因的双基因突变美国
-
M.D. Anderson Cancer Center撤销
-
US Department of Veterans Affairs完全的心脏衰竭 | Beta-blocker Treatment美国
-
Seoul National University Bundang HospitalSamsung Medical Center; Wonju Severance Christian Hospital招聘中
-
Thomas Jefferson UniversityGlaxoSmithKline; Drexel University未知
-
Centre Hospitalier Universitaire, AmiensCentre Hospitalier de Beauvais; University Hospital, Montpellier; University Hospital, Caen; Centre... 和其他合作者招聘中
-
Universidad Francisco de VitoriaUniversity of Seville; University of Greenwich完全的
-
Celgene终止
-
Singapore Institute for Clinical SciencesDSM Nutritional Products, Inc.完全的
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)招聘中
-
Groupe Hospitalier Paris Saint Joseph招聘中
-
University of British Columbia完全的
-
Lin Chen完全的
-
Hamad Medical Corporation招聘中
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA招聘中Β-地中海贫血美国, 火鸡, 意大利, 泰国, 德国, 希腊, 中国, 印度, 黎巴嫩
-
Vertex Pharmaceuticals IncorporatedCRISPR Therapeutics主动,不招人
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical University邀请报名
-
Rare Partners srl Impresa SocialeUniversità degli Studi di Ferrara完全的
-
IRCCS San RaffaeleOrchard Therapeutics; Fondazione Telethon未知
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI); George Papanicolaou Hospital完全的
-
bluebird bioCenter for International Blood and Marrow Transplant Research招聘中
-
Children's Hospital of Fudan UniversityCorrectSequence Therapeutics Co., Ltd招聘中
-
Vertex Pharmaceuticals IncorporatedCRISPR Therapeutics招聘中血液病 | 先天性遗传病 | 血红蛋白病 | 地中海贫血 | Β-地中海贫血美国, 德国, 意大利, 英国, 加拿大